S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Forecast, Price & News

$62.24
+1.83 (+3.03%)
(As of 05/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$60.36
$62.26
50-Day Range
$56.12
$70.49
52-Week Range
$51.66
$73.85
Volume
250,257 shs
Average Volume
366,456 shs
Market Capitalization
$3.53 billion
P/E Ratio
74.10
Dividend Yield
N/A
Beta
1.02
30 days | 90 days | 365 days | Advanced Chart
Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Merit Medical Systems logo

About Merit Medical Systems

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,446
Year Founded
1987

Sales & Book Value

Annual Sales
$1.07 billion
Cash Flow
$4.36 per share
Book Value
$18.42 per share

Profitability

Net Income
$48.45 million
Pretax Margin
5.03%

Debt

Price-To-Earnings

Miscellaneous

Free Float
54,527,000
Market Cap
$3.53 billion
Optionable
Optionable

Company Calendar

Last Earnings
4/27/2022
Today
5/17/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.00 out of 5 stars

Medical Sector

590th out of 1,426 stocks

Surgical & Medical Instruments Industry

71st out of 138 stocks

Analyst Opinion: 2.4Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

Is Merit Medical Systems a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems
or view top-rated stocks.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Merit Medical Systems
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its quarterly earnings data on Wednesday, April, 27th. The medical instruments supplier reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.06. Merit Medical Systems had a net margin of 4.36% and a trailing twelve-month return on equity of 13.33%. During the same quarter in the prior year, the company earned $0.52 earnings per share.
View Merit Medical Systems' earnings history
.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY22 earnings guidance on Wednesday, April, 27th. The company provided EPS guidance of $2.41-2.56 for the period, compared to the consensus earnings per share estimate of $2.48. The company issued revenue guidance of $1.117-1.140 billion, compared to the consensus revenue estimate of $1.13 billion.

What price target have analysts set for MMSI?

5 equities research analysts have issued 12 month price objectives for Merit Medical Systems' shares. Their forecasts range from $72.00 to $78.00. On average, they anticipate Merit Medical Systems' share price to reach $74.40 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price.
View analysts' price targets for Merit Medical Systems
or view top-rated stocks among Wall Street analysts.

Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the following people:
  • Mr. Fred P. Lampropoulos, Founder, Chairman, CEO & Pres (Age 72, Pay $3.39M)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer (Age 43, Pay $1.01M)
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 61, Pay $965.29k) (LinkedIn Profile)
  • Mr. Joseph C. Wright, Pres of International Division (Age 52, Pay $948.74k) (LinkedIn Profile)
  • Mr. Neil Peterson, Chief Operating Officer
  • Mr. Jason Treft, Chief Technology Officer
  • Mr. Joseph Pierce, Chief Information Officer
  • Mr. Michel J. Voigt, Chief HR Officer (Age 49)
  • Mr. John Knorpp, Chief Regulatory Affairs Officer
  • Dr. Nicole Priest, Chief Wellness Officer
What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems CEO Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among Merit Medical Systems' employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.83%), Vanguard Group Inc. (10.24%), William Blair Investment Management LLC (5.92%), Conestoga Capital Advisors LLC (4.48%), State Street Corp (3.32%) and Dimensional Fund Advisors LP (2.83%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems
.

Which major investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Starboard Value LP, Goldman Sachs Group Inc., Invesco Ltd., Polar Capital Holdings Plc, Emerald Mutual Fund Advisers Trust, Rothschild & Co. Asset Management US Inc., State Street Corp, and AlphaCrest Capital Management LLC. Company insiders that have sold Merit Medical Systems company stock in the last year include Brian G Lloyd, Jill Anderson, Joseph Wright, Lynne Ward, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems
or view top insider-selling stocks.

Which major investors are buying Merit Medical Systems stock?

MMSI stock was acquired by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Vanguard Group Inc., BlackRock Inc., Loomis Sayles & Co. L P, Allianz Asset Management GmbH, Assenagon Asset Management S.A., Emerald Advisers LLC, and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for Merit Medical Systems
or or view top insider-buying stocks.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $62.24.

How much money does Merit Medical Systems make?

Merit Medical Systems has a market capitalization of $3.53 billion and generates $1.07 billion in revenue each year. The medical instruments supplier earns $48.45 million in net income (profit) each year or $0.84 on an earnings per share basis.

How many employees does Merit Medical Systems have?

Merit Medical Systems employs 6,446 workers across the globe.

Does Merit Medical Systems have any subsidiaries?

The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.

When was Merit Medical Systems founded?

Merit Medical Systems was founded in 1987.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is www.merit.com.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at [email protected], or via fax at 801-253-1652.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.